LABORATORY RESEARCH p53-Independent Regulation of p21Waf1/Cip1 Expression and Senescence by PRMT6 The authors concluded that protein arginine methyltransferase 6 acts as an oncogene in breast cancer cells, promoting growth and preventing senescence, making it an attractive target for cancer therapy. [Nucleic Acids Res] Full Article Targeting BRCA1 Localization to Augment Breast Tumor Sensitivity to Poly(ADP-ribose) Polymerase Inhibition In human sporadic breast cancer cells with functional BRCA1 and proficient double strand break repair, a transient nuclear depletion of BRCA1 and subsequent homologous recombination repair deficit was induced with either truncated BRCA1 or irradiation. This rendered these human sporadic breast cancer cells susceptible to poly(ADP-ribose) polymerase inhibition. [Cancer Res] Abstract | Press Release Crosstalk Between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells Scientists report that the estrogen receptor coactivator MED1 is a novel crosstalk point for the HER2 and ERα pathways. Their results additionally indicated that MED1 is recruited to the HER2 gene and required for its expression. [Cancer Res] Abstract ROCK1 Inhibition Promotes the Self-Renewal of a Novel Mouse Mammary Cancer Stem Cell Researchers discuss the propagation of highly enriched mouse mammary cancer stem cells that retain the potential to differentiate both in vivo and in culture and their use to identify chemical compounds that influence both self-renewal and differentiation. They identified epithelial tumor initiating cells that express lineage markers of both basal and luminal mammary cell lineages and retain the potential, from even single cells, to generate heterogeneous tumors similar to the tumor of origin. [Stem Cells] Abstract Obesity-Associated Dysregulation of Calpastatin and MMP-15 in Adipose-Derived Stromal Cells Results in their Enhanced Invasion R1 To understand how adipose-derived stromal cells (ASCs) affect breast cancer cells, it is necessary to delineate how they mobilize and home to cancer cells, which requires mobilization and invasion through extracellular matrix barriers. ASCs isolated from the subcutaneous abdominal adipose tissue of obese patients demonstrated increased invasion through Matrigel as well as a chick chorioallantoic membrane, a type I collagen-rich extracellular matrix barrier. [Stem Cells] Abstract TGFß Induces the Formation of Tumor-Initiating Cells in Claudinlow Breast Cancer Examiners showed that TGFß increases breast tumor-initiating cell numbers, but only in claudinlow breast cancer cell lines, by orchestrating a specific gene signature enriched in stem cell processes that predicts worse clinical outcome in breast cancer patients. [Nat Commun] Abstract EZH2 Promotes a Bi-Lineage Identity in Basal-Like Breast Cancer Cells Investigators showed that the Polycomb factor EZH2 maintains the differentiation state of basal-like breast cancer cells, and promotes the expression of progenitor-associated and basal-lineage genes. EZH2 regulates the composition of basal-like breast cancer cell populations by promoting a ‘bi-lineage’ differentiation state, in which cells co-express basal- and luminal-lineage markers. [Oncogene] Abstract Lipocalin 2 Is a Novel Regulator of Angiogenesis in Human Breast Cancer The authors had previously reported that Lipocalin 2 (Lcn2) induces the epithelial to mesenchymal transition in breast cancer through the estrogen receptor a/Slug axis and that it is a potential noninvasive biomarker of the disease. Here, they report the novel finding that Lcn2 regulates breast cancer angiogenesis. [FASEB J] Abstract HuR Is Necessary for Mammary Epithelial Cell Proliferation and Polarity at Least in Part via ΔNp63 Scientists showed that in immortalized MCF10A mammary epithelial cells, HuR knockdown inhibits cell proliferation and enhances premature senescence. They also showed that in three-dimensional culture, MCF10A cells with HuR knockdown form abnormal acini with filled lumen and an aberrant expression pattern of the extracellular matrix protein laminin V. [PLoS One] Full Article CLINICAL RESEARCH Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer Scientists assessed the gene transcripts of epithelial-to-mesenchymal transition (EMT) inducing transcription factors and cancer stem cell features in HER2+ metastatic breast cancer (MBC) patients. The data indicated that HER2+ MBC patients have EMT-circulating tumor cells. [Mol Cancer Ther] Abstract Impact of Breast Cancer Subtypes and Treatment on Survival: An Analysis Spanning Two Decades Researchers investigated the impact of breast cancer molecular subtypes and treatment on survival in a cohort of medically insured women followed for more than 20 years. Women with HER2-enriched tumors and luminal B subtypes had the poorest survival despite adjusting for important covariates. [Cancer Epidemiol Biomarkers Prev] Abstract | Press Release &u=http://www.stemcell.com/en/Technical-Resources/11192/ALDH-Cancer-Precursor-Cells-in-Drug-Response-Prediction.aspx?utm_source=mcn%26utm_medium=banner%26utm_campaign=edfieldwebinararchived&t=(Archive)MCN4.37ii”> |